<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d223">
    <sentence id="DDI-DrugBank.d223.s0" text="Drugs Metabolized by P450 2D6: The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7-10% of Caucasians are so-called poor metabolizers);"/>
    <sentence id="DDI-DrugBank.d223.s1" text="reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."/>
    <sentence id="DDI-DrugBank.d223.s2" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.">
        <entity id="DDI-DrugBank.d223.s2.e0" charOffset="69-93"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s2.e1" charOffset="96-99"
            type="group" text="TCAs"/>
        <pair id="DDI-DrugBank.d223.s2.p0" e1="DDI-DrugBank.d223.s2.e0"
            e2="DDI-DrugBank.d223.s2.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s3" text="Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."/>
    <sentence id="DDI-DrugBank.d223.s4" text="In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."/>
    <sentence id="DDI-DrugBank.d223.s5" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.">
        <entity id="DDI-DrugBank.d223.s5.e0" charOffset="47-49"
            type="group" text="TCA"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s6" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine;">
        <entity id="DDI-DrugBank.d223.s6.e0" charOffset="96-104"
            type="drug" text="quinidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s7" text="cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).">
        <entity id="DDI-DrugBank.d223.s7.e0" charOffset="0-9"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s7.e1" charOffset="66-80"
            type="group" text="antidepressants"/>
        <entity id="DDI-DrugBank.d223.s7.e2" charOffset="83-96"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d223.s7.e3" charOffset="107-129"
            type="group" text="Type 1C antiarrhythmics"/>
        <entity id="DDI-DrugBank.d223.s7.e4" charOffset="131-141"
            type="drug" text="propafenone"/>
        <entity id="DDI-DrugBank.d223.s7.e5" charOffset="147-156"
            type="drug" text="flecainide"/>
        <pair id="DDI-DrugBank.d223.s7.p0" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p1" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p2" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p3" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p4" e1="DDI-DrugBank.d223.s7.e0"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p5" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p6" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p7" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p8" e1="DDI-DrugBank.d223.s7.e1"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p9" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p10" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p11" e1="DDI-DrugBank.d223.s7.e2"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p12" e1="DDI-DrugBank.d223.s7.e3"
            e2="DDI-DrugBank.d223.s7.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p13" e1="DDI-DrugBank.d223.s7.e3"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s7.p14" e1="DDI-DrugBank.d223.s7.e4"
            e2="DDI-DrugBank.d223.s7.e5" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s8" text="While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.">
        <entity id="DDI-DrugBank.d223.s8.e0" charOffset="14-52"
            type="group" text="selective serotonin reuptake inhibitors"/>
        <entity id="DDI-DrugBank.d223.s8.e1" charOffset="55-59"
            type="group" text="SSRIs"/>
        <entity id="DDI-DrugBank.d223.s8.e2" charOffset="69-78"
            type="drug" text="citalopram"/>
        <entity id="DDI-DrugBank.d223.s8.e3" charOffset="81-92"
            type="drug" text="escitalopram"/>
        <entity id="DDI-DrugBank.d223.s8.e4" charOffset="95-104"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d223.s8.e5" charOffset="107-116"
            type="drug" text="sertraline"/>
        <entity id="DDI-DrugBank.d223.s8.e6" charOffset="123-132"
            type="drug" text="paroxetine"/>
        <pair id="DDI-DrugBank.d223.s8.p0" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p1" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p2" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p3" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p4" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p5" e1="DDI-DrugBank.d223.s8.e0"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p6" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p7" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p8" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p9" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p10" e1="DDI-DrugBank.d223.s8.e1"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p11" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p12" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p13" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p14" e1="DDI-DrugBank.d223.s8.e2"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p15" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e4" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p16" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p17" e1="DDI-DrugBank.d223.s8.e3"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p18" e1="DDI-DrugBank.d223.s8.e4"
            e2="DDI-DrugBank.d223.s8.e5" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p19" e1="DDI-DrugBank.d223.s8.e4"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s8.p20" e1="DDI-DrugBank.d223.s8.e5"
            e2="DDI-DrugBank.d223.s8.e6" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s9" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.">
        <entity id="DDI-DrugBank.d223.s9.e0" charOffset="20-23"
            type="group" text="SSRI"/>
        <entity id="DDI-DrugBank.d223.s9.e1" charOffset="25-27"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d223.s9.e2" charOffset="141-144"
            type="group" text="SSRI"/>
        <pair id="DDI-DrugBank.d223.s9.p0" e1="DDI-DrugBank.d223.s9.e0"
            e2="DDI-DrugBank.d223.s9.e1" ddi="true" type="int"/>
        <pair id="DDI-DrugBank.d223.s9.p1" e1="DDI-DrugBank.d223.s9.e0"
            e2="DDI-DrugBank.d223.s9.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s9.p2" e1="DDI-DrugBank.d223.s9.e1"
            e2="DDI-DrugBank.d223.s9.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s10" text="Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other.">
        <entity id="DDI-DrugBank.d223.s10.e0" charOffset="63-66"
            type="group" text="TCAs"/>
        <entity id="DDI-DrugBank.d223.s10.e1" charOffset="84-88"
            type="group" text="SSRIs"/>
        <pair id="DDI-DrugBank.d223.s10.p0"
            e1="DDI-DrugBank.d223.s10.e0" e2="DDI-DrugBank.d223.s10.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s11" text="Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).">
        <entity id="DDI-DrugBank.d223.s11.e0" charOffset="120-129"
            type="drug" text="fluoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s12" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.">
        <entity id="DDI-DrugBank.d223.s12.e0" charOffset="19-43"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s12.e1" charOffset="156-179"
            type="group" text="tricyclic antidepressant"/>
        <pair id="DDI-DrugBank.d223.s12.p0"
            e1="DDI-DrugBank.d223.s12.e0" e2="DDI-DrugBank.d223.s12.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s13" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required.">
        <entity id="DDI-DrugBank.d223.s13.e0" charOffset="98-121"
            type="group" text="tricyclic antidepressant"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s14" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.">
        <entity id="DDI-DrugBank.d223.s14.e0" charOffset="27-29"
            type="group" text="TCA"/>
        <entity id="DDI-DrugBank.d223.s14.e1" charOffset="56-58"
            type="group" text="TCA"/>
        <pair id="DDI-DrugBank.d223.s14.p0"
            e1="DDI-DrugBank.d223.s14.e0" e2="DDI-DrugBank.d223.s14.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s15" text="Doxepin is primarily metabolized by CYP2D6 (with CYP1A2  and  CYP3A4 as minor pathways).">
        <entity id="DDI-DrugBank.d223.s15.e0" charOffset="0-6"
            type="drug" text="Doxepin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s16" text="Inhibitors or substrates of CYP2D6 (i.e., quinidine, selective serotonin reuptake inhibitors [SSRIs]) may increase the plasma concentration of doxepin when administered concomitantly.">
        <entity id="DDI-DrugBank.d223.s16.e0" charOffset="42-50"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d223.s16.e1" charOffset="53-91"
            type="group" text="selective serotonin reuptake inhibitors"/>
        <entity id="DDI-DrugBank.d223.s16.e2" charOffset="94-98"
            type="group" text="SSRIs"/>
        <entity id="DDI-DrugBank.d223.s16.e3" charOffset="143-149"
            type="drug" text="doxepin"/>
        <pair id="DDI-DrugBank.d223.s16.p0"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p1"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p2"
            e1="DDI-DrugBank.d223.s16.e0" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d223.s16.p3"
            e1="DDI-DrugBank.d223.s16.e1" e2="DDI-DrugBank.d223.s16.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s16.p4"
            e1="DDI-DrugBank.d223.s16.e1" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d223.s16.p5"
            e1="DDI-DrugBank.d223.s16.e2" e2="DDI-DrugBank.d223.s16.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s17" text="The extent of interaction depends on the variability of effect on CYP2D6."/>
    <sentence id="DDI-DrugBank.d223.s18" text="The clinical significance of this interaction with doxepin has not been systematically evaluated.">
        <entity id="DDI-DrugBank.d223.s18.e0" charOffset="51-57"
            type="drug" text="doxepin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s19" text="MAO Inhibitors: Serious side effects and even death have been reported following the concomitant use of certain drugs with MAO inhibitors.">
        <entity id="DDI-DrugBank.d223.s19.e0" charOffset="0-13"
            type="group" text="MAO Inhibitors"/>
        <entity id="DDI-DrugBank.d223.s19.e1" charOffset="123-136"
            type="group" text="MAO inhibitors"/>
        <pair id="DDI-DrugBank.d223.s19.p0"
            e1="DDI-DrugBank.d223.s19.e0" e2="DDI-DrugBank.d223.s19.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s20" text="Therefore, MAO inhibitors should be discontinued at least two weeks prior to the cautious initiation of therapy with SINEQUAN.">
        <entity id="DDI-DrugBank.d223.s20.e0" charOffset="11-24"
            type="group" text="MAO inhibitors"/>
        <entity id="DDI-DrugBank.d223.s20.e1" charOffset="117-124"
            type="brand" text="SINEQUAN"/>
        <pair id="DDI-DrugBank.d223.s20.p0"
            e1="DDI-DrugBank.d223.s20.e0" e2="DDI-DrugBank.d223.s20.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s21" text="The exact length of time may vary and is dependent upon the particular MAO inhibitor being used, the length of time it has been administered, and the dosage involved.">
        <entity id="DDI-DrugBank.d223.s21.e0" charOffset="71-83"
            type="group" text="MAO inhibitor"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s22" text="Cimetidine: Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants.">
        <entity id="DDI-DrugBank.d223.s22.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d223.s22.e1" charOffset="12-21"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d223.s22.e2" charOffset="136-160"
            type="group" text="tricyclic antidepressants"/>
        <pair id="DDI-DrugBank.d223.s22.p0"
            e1="DDI-DrugBank.d223.s22.e0" e2="DDI-DrugBank.d223.s22.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s22.p1"
            e1="DDI-DrugBank.d223.s22.e0" e2="DDI-DrugBank.d223.s22.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s22.p2"
            e1="DDI-DrugBank.d223.s22.e1" e2="DDI-DrugBank.d223.s22.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s23" text="Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of tricyclic antidepressant when cimetidine therapy is initiated.">
        <entity id="DDI-DrugBank.d223.s23.e0" charOffset="156-179"
            type="group" text="tricyclic antidepressant"/>
        <entity id="DDI-DrugBank.d223.s23.e1" charOffset="186-195"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d223.s23.p0"
            e1="DDI-DrugBank.d223.s23.e0" e2="DDI-DrugBank.d223.s23.e1"
            ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s24" text="Additionally, higher than expected tricyclic antidepressant levels have been observed when they are begun in patients already taking cimetidine.">
        <entity id="DDI-DrugBank.d223.s24.e0" charOffset="35-58"
            type="group" text="tricyclic antidepressant"/>
        <entity id="DDI-DrugBank.d223.s24.e1" charOffset="133-142"
            type="drug" text="cimetidine"/>
        <pair id="DDI-DrugBank.d223.s24.p0"
            e1="DDI-DrugBank.d223.s24.e0" e2="DDI-DrugBank.d223.s24.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s25" text="In patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy, discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects.">
        <entity id="DDI-DrugBank.d223.s25.e0" charOffset="60-84"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d223.s25.e1" charOffset="107-116"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s25.e2" charOffset="146-155"
            type="drug" text="cimetidine"/>
        <entity id="DDI-DrugBank.d223.s25.e3" charOffset="218-241"
            type="group" text="tricyclic antidepressant"/>
        <pair id="DDI-DrugBank.d223.s25.p0"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p1"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p2"
            e1="DDI-DrugBank.d223.s25.e0" e2="DDI-DrugBank.d223.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p3"
            e1="DDI-DrugBank.d223.s25.e1" e2="DDI-DrugBank.d223.s25.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p4"
            e1="DDI-DrugBank.d223.s25.e1" e2="DDI-DrugBank.d223.s25.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s25.p5"
            e1="DDI-DrugBank.d223.s25.e2" e2="DDI-DrugBank.d223.s25.e3"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s26" text="Alcohol: It should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional SINEQUAN overdosage.">
        <entity id="DDI-DrugBank.d223.s26.e0" charOffset="0-6"
            type="drug" text="Alcohol"/>
        <entity id="DDI-DrugBank.d223.s26.e1" charOffset="41-47"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d223.s26.e2" charOffset="128-135"
            type="brand" text="SINEQUAN"/>
        <pair id="DDI-DrugBank.d223.s26.p0"
            e1="DDI-DrugBank.d223.s26.e0" e2="DDI-DrugBank.d223.s26.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s26.p1"
            e1="DDI-DrugBank.d223.s26.e0" e2="DDI-DrugBank.d223.s26.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s26.p2"
            e1="DDI-DrugBank.d223.s26.e1" e2="DDI-DrugBank.d223.s26.e2"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s27" text="This is especially important in patients who may use alcohol excessively.">
        <entity id="DDI-DrugBank.d223.s27.e0" charOffset="53-59"
            type="drug" text="alcohol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d223.s28" text="Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of doxepin (75 mg/day).">
        <entity id="DDI-DrugBank.d223.s28.e0" charOffset="0-9"
            type="drug" text="Tolazamide"/>
        <entity id="DDI-DrugBank.d223.s28.e1" charOffset="104-113"
            type="drug" text="tolazamide"/>
        <entity id="DDI-DrugBank.d223.s28.e2" charOffset="156-162"
            type="drug" text="doxepin"/>
        <pair id="DDI-DrugBank.d223.s28.p0"
            e1="DDI-DrugBank.d223.s28.e0" e2="DDI-DrugBank.d223.s28.e1" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s28.p1"
            e1="DDI-DrugBank.d223.s28.e0" e2="DDI-DrugBank.d223.s28.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d223.s28.p2"
            e1="DDI-DrugBank.d223.s28.e1" e2="DDI-DrugBank.d223.s28.e2"
            ddi="true" type="effect"/>
    </sentence>
</document>
